Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been somewhat neglected. It nevertheless represents a major health problem in these patients, and is associ...
Alternative Titles
Full title
Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2024796197
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2024796197
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0195876
